Categories: Education

Here are some of the standout moments from 2024 that drove our commitment to leadership in research, education, patient care, and innovation, all aimed at expanding knowledge and enhancing health worldwide.

The first program of its kind in the United States, the MS in AICD3 is enabling its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.

June 14, 2024, marked the 15-year collaboration of a Chinese course improving medical product development and regulation.

The pioneering career of one of the School’s most influential faculty members was honored on his 87th birthday.

The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.

Su Guo, PhD, will lead a new center to increase collaboration between clinical, translational, and discovery science in teaching and research.

Students keep pace with latest innovations through experiential options and advanced degrees.

A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.

Honoring the School’s newest PharmD graduates.

PSPG and BMI graduate students will bring their scientific talents and passion for equity to Genentech during their summer internships.